Illustration: Rebecca Zisser / Axios

CRISPR, the precision gene-editing technology researchers hope can be used to treat genetic illnesses, may be ineffective or even dangerous for a large subset of humans, according to STAT news. A new paper reports many people may be immune to the two most commonly used types of CRISPR. However, some scientists told STAT it may be possible to work around this problem.

Why it matters: We're moving closer to using CRISPR in human trials, but if the results of this paper are confirmed (it hasn't been peer reviewed yet) it's possible the treatment could be stopped by the immune system, or worse, trigger a dangerous inflammatory immune response.

The background: CRISPR is a suite of genes that bacteria use as an immune system to fight viruses. The genes can cut and splice parts of a bacteria's genome — and, in the lab, human genomes. Other parts of the CRISPR suite might be used to edit RNA, create cellular recorders, diagnose diseases or to kill bacteria without antibiotics.

What they found: Since CRISPR comes from bacteria, it makes sense that our body's immune systems would recognize and attack it, and the bacteria we've taken CRISPR from are some of the most common ones humans encounter.

  • 65% of people have immune proteins for the CRISPR Cas9 genome that comes from the bacteria Staphylococcus pyogenes (strep throat), and 75% are immune to CRISPR that comes from Staphylococcus aureus (staph infections), the two most common types of CRISPR.
  • Immune cells in about half of the people studied targeted CRISPR from S. aureus. It's unknown if other parts of the CRISPR suite besides Cas9 would be affected.

Yes, but this doesn't spell the end of CRISPR. "“At the end of the day, I’m not that concerned about it,” Daniel Anderson of the Massachusetts Institute of Technology, tells STAT. “But we want to do some experiments to learn more.”

There are workarounds: Currently, many CRISPR proposals involve editing a person's cells outside of the body, and then adding the cells back in, thus circumventing the immune system. It's possible that other CRISPR proteins won't be detected by the human body.

Proceed with caution: Study author Matthew Porteus of Stanford told STAT the field can't afford a death, noting the 1999 death of a man in a gene therapy trial, who was thought to have died from an immune response. "I would hate to see the field have a major setback because we didn’t address this potential issue,” Porteus said.

Go deeper

Updated 16 mins ago - World

At least 50 killed, 3,000 injured after massive explosion rocks Beirut

Photo: Anwar Amro/AFP via Getty Images

A major explosion has slammed central Beirut, Lebanon, damaging buildings as far as several miles away and injuring scores of people.

Driving the news: The cause of the explosion is unknown. Lebanon's health minister said in televised remarks that more than 50 people have been killed and over 3,000 injured.

52 mins ago - Podcasts

The debate over COVID-19 liability protections

Stimulus talks continue to move slowly, with Democrats and Republicans unable to agree on whether or not to include coronavirus-related liability protections for businesses, health facilities and schools.

Axios Re:Cap digs into the debate, which could reset the cost-benefit analysis for businesses thinking about reopening and employees thinking about returning.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 p.m. ET: 18,364,694 — Total deaths: 695,848 — Total recoveries — 10,965,634Map.
  2. U.S.: Total confirmed cases as of 3 p.m. ET: 4,742,277 — Total deaths: 156,133 — Total recoveries: 1,513,446 — Total tests: 57,543,852Map.
  3. States: New York City health commissioner resigns in protest of De Blasio's coronavirus response — New York ER doctor on pandemic advice: "We know what works"
  4. Public health: 59% of Americans support nationwide 2-week stay-at-home order in NPR poll Atrium Health CEO says "virtual hospital" has treated 13,000 COVID patients.
  5. Politics: Republicans push to expand small business loan program Trump tells "Axios on HBO" that pandemic is "under control," despite surges in infections.
  6. Sports: Indy 500 to be held without fansRafael Nadal opts out of U.S. Open.